Patents
| Title | Publication number | Applicant* |
|---|---|---|
| 1,2,4-triazole derivatives as tankyrase inhibitors | WO 2019243822 A1 | Oslo Univ Hospital, FVB, Univ Oulo |
| Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors | WO 2019234237 A1 | FVB |
| Polyproline mimetics of proline-derived module-15 | WO 2019162524 A1 | FVB, Univ zu Köln |
| Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways | CA 3041832 A1, AU 2017359276 A1, US 2019276452 A1, EP 3538529 A1, JP 2019535709 A, CN 109963850 A | MDC, FVB |
| Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates | WO 2019170710 A3 | FVB, LMU |
| Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates | US 2019330264 A1, CA 3032251 A1, AU 2017320913 A1, CN 109689112 A, JP 2019532041 A, EP 3506949 A1 | FVB, LMU |
| Molecular sensor for NMR/MRI based on analyte-dependent spectral changes of temporarily encapsulated hyperpolarized 129Xe | EP 3491389 A1, US 2019307907 A1 | TUM, FVB |
| Unusual substrates of tubulin tyrosine ligase | AU 2017255938 A1, US 2019144493 A1, EP 3448870 A1, CA 3021526 A1 | FVB, LMU |
| Antagonists of the thyroid-stimulating hormone receptor (TSHR) | EP 3448381 A1, US 2019134024 A1 | FVB |
| Means and methods for site-specific functionalization of polypeptides | US 10208084 B2, US 2019337977 A1, EP 3212659 A1, CA 2964837 A1, AU 2015340591 A1 | LMU, FVB |
| Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same | US 10214530 B2, EP 3262044 B1, US 2019161503 A1, EP 3490996 A1 | FVB, MDC |
| Inhibitors for inhibiting tumor metastasis | US 10344053 B2, EP 3230300 A1 | FVB, Univ zu Köln |
| LRRC8 proteins and protein complexes and methods for identification of channel modulators | US 9927423 B2, EP 2919009 B1 | FVB, MDC |
| Structural mimetics of proline-rich peptides and use thereof | US 9242985 B2, JP 2017165761 A, EP 2747764 B1 | FVB, Univ zu Köln |
| Induction of alpha helix conformations in proteins and peptides | US 8815932 B2, EP 2451815 B1 | Univ zu Köln, FVB |
| Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists | US 8741259 B2, US 9187457 B2, US 9296729 B2, US 9458141 B2, JP 5718233 B2, JP 2012506841 A, EP 2358684 B8, AU 2008363295 B2, AU 2015204281 B2, AU 2016204845 B2 | US Health, FVB |
| Structural mimetics of proline-rich peptides and the pharmaceutical use thereof | US 8242105 B2, JP 5588172 B2, EP 2094711 B8 | FVB |
*FVB - Forschungsverbund Berlin e.V. (for its Leibniz-Forschungsinstitut für Molekulare Pharmakologie); LMU - Ludwig-Maximilians-Universität München; MDC - Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft; Oslo Univ Hospital - Oslo University Hospital HF; TUM - Technische Universität München; Univ Oulo - University of Oulo; Univ zu Köln - Universität zu Köln; US Health - The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
